Martin Shkreli: entrepreneur defends decision to raise price of life-saving drug 50-fold

An entrepreneur who acquired the rights to produce a life-saving drug then increased its price more than 50-fold overnight is defending his decision with assertions that the profits will help create better medicines in future.
Medical organizations protested loudly on Sunday after a company owned by controversial former hedge fund manager Martin Shkreli raised the price of the drug Daraprim, which treats a dangerous parasitic infection, from $13.50 per pill to $750 per pill.
Shkreli’s startup company, Turing Pharmaceuticals, acquired Daraprim in August. The drug was first developed in the... read more

 
10 March 2018 in Business, Views: 57
Source: Guardian
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30